Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients

被引:251
作者
Levrat, A. [3 ]
Gros, A. [3 ]
Rugeri, L. [4 ,5 ]
Inaba, K. [6 ]
Floccard, B. [3 ]
Negrier, C. [4 ,5 ]
David, J. -S. [1 ,2 ]
机构
[1] Hosp Civils Lyon, Lyon Sud Hosp, Dept Anesthesiol & Crit Care, F-69495 Pierre Benite, France
[2] Univ Lyon 1, F-69495 Pierre Benite, France
[3] Hop Edouard Herriot, Hosp Civils Lyon, Dept Anesthesia & Crit Care, F-69437 Lyon, France
[4] Hop Edouard Herriot, Hosp Civils Lyon, Div Haemostasis, F-69437 Lyon, France
[5] Univ Lyon 1, F-69437 Lyon, France
[6] Univ So Calif, Div Trauma & Crit Care, Dept Surg, LAC USC Med Ctr, Los Angeles, CA 90033 USA
关键词
blood; haemostasis; complications; bleeding; coagulopathy; trauma;
D O I
10.1093/bja/aen083
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background. Blood loss and uncontrollable bleeding are major factors affecting survival in trauma patients. Because treatment with antifibrinolytic drugs may be effective, early detection of hyperfibrinolysis with rotation thrombelastography (ROTEM (R)) may be beneficial. Methods. Eighty-seven trauma patients were included in this prospective observational study. Blood samples were collected at admission. After in vitro activation with tissue factor (EXTEM) and inhibition with aprotinin (APTEM), ROTEM (R) parameters including maximal clot firmness (MCF) and clot lysis index at 30 min (CLI30) were determined. Hyperfibrinolysis was defined as a euglobulin lysis time (ELT) < 90 min. Threshold for ROTEM (R) parameters were determined with receiver-operating characteristic curves (ROC) analysis according to the ELT results. Results. ELT was determined in a subgroup of 23 patients. In this group of patients, ROC analysis showed that for a threshold of 18 mm (MCF-EXTEM), 71% (CLI30) and 7% (increase of MCF-APTEM), sensitivity was, respectively, 100%, 75%, and 80% with a specificity of 100%. With the application of these thresholds to the whole trauma cohort, ROTEM (R) analysis detected hyperfibrinolysis in five patients [6%, 95% confidence interval (CI): 2-13%]. As expected, patients with hyperfibrinolysis were more severely injured (median Injury Severity Score: 75 vs 20, P < 0.05), had greater coagulation abnormalities [international normalized ratio (INR): 8.2 vs 1.3, P < 0.05; fibrinogen: 0.0 vs 2.2 g litre(-1), P < 0.05], and a higher mortality rate (100%, CI: 48-100% vs 11% CI: 5-20%, P < 0.05). Conclusions. ROTEM (R) provided rapid and accurate detection of hyperfibrinolysis in severely injured trauma patients.
引用
收藏
页码:792 / 797
页数:6
相关论文
共 37 条
  • [1] INJURY SEVERITY SCORE - METHOD FOR DESCRIBING PATIENTS WITH MULTIPLE INJURIES AND EVALUATING EMERGENCY CARE
    BAKER, SP
    ONEILL, B
    HADDON, W
    LONG, WB
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1974, 14 (03): : 187 - 196
  • [2] Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients
    Borawski, J
    Mysliwiec, M
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (04) : 296 - 299
  • [3] A new device for measurement of fibrin clot lysis: Application to the Euglobulin Clot Lysis Time
    Zouaoui Boudjeltia K.
    Cauchie Ph.
    Remacle Cl.
    Guillaume M.
    Brohée D.
    Hubert J.L.
    Vanhaeverbeek M.
    [J]. BMC Biotechnology, 2 (1)
  • [4] Acute traumatic coagulopathy
    Brohi, K
    Singh, J
    Heron, M
    Coats, T
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 54 (06): : 1127 - 1130
  • [5] Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery
    Brown, Jeremiah R.
    Birkmeyer, Nancy J. O.
    O'Connor, Gerald T.
    [J]. CIRCULATION, 2007, 115 (22) : 2801 - 2813
  • [6] Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement:: a randomized clinical trial
    Camarasa, MA
    Ollé, G
    Serra-Prat, M
    Martín, A
    Sánchez, M
    Ricós, P
    Pérez, A
    Opisso, L
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2006, 96 (05) : 576 - 582
  • [7] CHERAS PA, 1997, CLIN ORTHOP RELAT R, V334, P57
  • [8] COATS T, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004896.PUB2
  • [9] Evaluating the safety implications of aprotinin use: The retrospective evaluation of aprotinin in cardio thoracic surgery (REACTS)
    Coleman, Craig I.
    Rigali, Vera T.
    Hammond, Jonathan
    Kluger, Jeffrey
    Jeleniowski, Kenneth W.
    White, C. Michael
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (06) : 1547 - 1552
  • [10] COPLEY AL, 1959, J LAB CLIN MED, V53, P468